The Medical Advisors at Cornerstone Pharmaceuticals play a crucial role in bridging the gap between clinical research and practical application by providing expert guidance on metabolic oncology therapeutics. They collaborate with cross-functional teams to develop scientific strategies, support clinical trial designs, and ensure that the medical community is informed about the benefits and developments of innovative therapies. Their insights influence clinical practices and help shape the company’s overall medical strategy.
Ariela Noy
Medical Advisor
Bayard L. Powell
Medical Advisor
Craig H. Moskowitz
Medical Advisor
Eric Van Cutsem
Medical Advisor
Heloisa P. Soares
Medical Advisor
J. Randolph Hecht
Medical Advisor
Jorge Cortes
Medical Advisor
Josep Tabernero
Medical Advisor
Mikkael Sekeres
Medical Advisor
Richard M. Stone
Medical Advisor
View all